摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,6-dimethoxy-4-methyl-pyridine

中文名称
——
中文别名
——
英文名称
2,6-dimethoxy-4-methyl-pyridine
英文别名
2,6-Dimethoxy-4-methyl-pyridin;2,6-Dimethoxy-4-methylpyridine
2,6-dimethoxy-4-methyl-pyridine化学式
CAS
——
化学式
C8H11NO2
mdl
——
分子量
153.181
InChiKey
HTWWVVPXJNVIRU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    11
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    31.4
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] OREXIN RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DU RÉCEPTEUR DE L'OREXINE
    申请人:HEPTARES THERAPEUTICS LTD
    公开号:WO2014006402A1
    公开(公告)日:2014-01-09
    The disclosures herein relate to novel compounds of formula wherein W, X and Y1, Y2, Y3 and Y4 are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of neurological or psychiatric disorders associated with orexin receptors.
    本公开涉及一种新型化合物的公式,其中W、X和Y1、Y2、Y3和Y4在此处定义,并其在治疗、预防、改善、控制或减少与促觉素受体相关的神经系统或精神障碍的风险中的用途。
  • [EN] PESTICIDAL COMPOUNDS<br/>[FR] COMPOSÉS PESTICIDES
    申请人:SYNGENTA PARTICIPATIONS AG
    公开号:WO2016012333A1
    公开(公告)日:2016-01-28
    A method of combating and controlling insects, acarines, nematodes or molluscs which comprises applying to a pest, to a locus of a pest, or to a plant susceptible to attack by a pest an insecticidally, acaricidally, nematicidally or molluscicidally effective amount of a compound of formula (I), wherein R1 is R4, YR5 or ZR6; Y is CO or C=S; Z is S, S(O), SO2 or PO2; and A is an optionally substituted phenyl or an optionally substituted heteroaromatic ring, wherein R1 to R6 are defined organic groups; new compounds are also provided.
    一种用于对抗和控制昆虫、螨虫、线虫或软体动物的方法,包括向害虫、害虫栖息地或易受害虫攻击的植物施加化学式(I)中的一种化合物的杀虫、杀螨、杀线虫或杀软体动物有效量,其中R1为R4、YR5或ZR6;Y为CO或C=S;Z为S、S(O)、SO2或PO2;A为一个可选择取代的苯基或可选择取代的杂环,其中R1至R6为定义的有机基团;还提供了新的化合物。
  • Pyridoindolone Derivatives Substituted in the 3-position by a Heterocyclic Group, Their Preparation and Their Application in Therapeutics
    申请人:BOURRIE Bernard
    公开号:US20090042924A1
    公开(公告)日:2009-02-12
    The present disclosure relates to pyridoindolone derivatives of general formula (I): in which R 1 to R 5 are as defined in the specification, to processes for preparing said derivatives, and to methods of use thereof.
    本公开涉及一般式(I)的吡啶并吲哚酮衍生物,其中R1至R5如规范中定义,以及制备该衍生物的过程和使用方法。
  • PROTEASOME INHIBITORS FOR SELECTIVELY INDUCING APOPTOSIS IN CANCER CELLS
    申请人:Lawrence Harshani
    公开号:US20110201609A1
    公开(公告)日:2011-08-18
    The subject invention concerns compounds having activity as inhibitors of proteasomes and methods of using the subject compounds. In one embodiment, a compound of the invention has the chemical structure shown in formula I: wherein R 1 is an organic cyclic ring structure bonded to a sulfonamide structure; R 2 is H, halogen, alkyl, —NR 6 R 7 , or heteroalkyl; R 3 is H, halogen, —OH, —O-alkyl, alkyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, —NO 2 , —NH 2 or substituted amines; R 4 is H, alkyl, heteroalkyl, aryl, or heteroaryl, any of which can be optionally substituted with one or more of —NO 2 , alkyl, heteroalkyl, aryl, or heteroaryl, or halogen; R 5 is H, —OH, halogen, alkyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, —O-alkyl, —O-aryl, heteroalkyl, —NO 2 , —NH 2 , or substituted amine; and R 6 and R 7 are independently H, O, alkyl, aryl, heterocycloalkyl, or heteroaryl, or together can form a heterocycloalkyl or a heteroaryl, any of which can be optionally substituted with one or more of —NO 2 , alkyl, heteroalkyl, aryl, or halogen; or a pharmaceutically acceptable salt or hydrate thereof. In another embodiment, a compound of the invention has the chemical structure shown in formula II: wherein Q, W, X, Y, Z are each independently carbon, oxygen, or nitrogen; R 1 is H, or X 1 R 8 ; R 2 is heteroalkyl, which can be optionally substituted with one or more of —OH, halogen, —C(O)OR 4 , alkyl, heteroalkyl, heterocycloalkyl, or heteroaryl; R 3 is heterocycloalkyl, aryl, heteroaryl, any of which can be optionally substituted with one or more of a halogen or —OH; and R 4 is H or alkyl; R 5 is halogen, alkyl or nitro; R 6 is nitro, X 2 R 9 or a halogen; R 7 is H or alkyl; R 8 is H, alkyl, aryl, CH 2 -alkyl-aryl, -alkyl-C(O)OH, or alkyl-tetrazole (aromatic and aliphatic heterocyclic groups); R 9 is H or alkyl; X 1 is oxygen, nitrogen, or sulfur; X 2 is oxygen, nitrogen, or sulfur; or a pharmaceutically acceptable salt or hydrate thereof.
    本发明涉及作为蛋白酶体抑制剂的化合物及使用该化合物的方法。在一种实施方式中,本发明的化合物具有公式I所示的化学结构:其中,R1是与磺酰胺结构键合的有机环状环结构;R2是H、卤素、烷基、-NR6R7或杂环烷基;R3是H、卤素、-OH、-O-烷基、烷基、环烷基、杂环烷基、芳基、杂芳基、-NO2、-NH2或取代胺;R4是H、烷基、杂烷基、芳基或杂芳基,其中任何一个都可以选择性地取代一个或多个-NO2、烷基、杂烷基、芳基或杂芳基或卤素;R5是H、-OH、卤素、烷基、芳基、杂芳基、环烷基、杂环烷基、-O-烷基、-O-芳基、杂烷基、-NO2、-NH2或取代胺;R6和R7分别是H、O、烷基、芳基、杂环烷基或杂芳基,或者一起形成杂环烷基或杂芳基,其中任何一个都可以选择性地取代一个或多个-NO2、烷基、杂烷基、芳基或卤素;或其药学上可接受的盐或水合物。在另一种实施方式中,本发明的化合物具有公式II所示的化学结构:其中,Q、W、X、Y、Z分别独立地是碳、氧或氮;R1是H或X1R8;R2是杂环烷基,可以选择性地取代一个或多个-OH、卤素、-C(O)OR4、烷基、杂烷基、杂环烷基或杂芳基;R3是杂环烷基、芳基、杂芳基,其中任何一个都可以选择性地取代一个或多个卤素或-OH;R4是H或烷基;R5是卤素、烷基或硝基;R6是硝基、X2R9或卤素;R7是H或烷基;R8是H、烷基、芳基、CH2-烷基-芳基、-烷基-C(O)OH或烷基-四唑(芳香和脂肪族杂环基);R9是H或烷基;X1是氧、氮或硫;X2是氧、氮或硫;或其药学上可接受的盐或水合物。
  • Azole Derivatives as WTN Pathway Inhibitors
    申请人:Holsworth Daniel
    公开号:US20120208828A1
    公开(公告)日:2012-08-16
    The present invention relates to new compounds of formula I, to processes for their preparation, to pharmaceutical formulations containing such compounds and to their use in therapy. Such compounds find particular use in the treatment and/or prevention of conditions or diseases which are affected by over-activation of signaling in the Wnt pathway. For example, these may be used in preventing and/or retarding proliferation of tumor cells, for example carcinomas such as colon carcinomas.
    本发明涉及公式I的新化合物,其制备过程,含有这些化合物的制药配方以及它们在治疗中的应用。这些化合物在防治或治疗Wnt通路信号过度激活引起的疾病或症状方面具有特殊用途。例如,它们可以用于预防和/或延缓肿瘤细胞的增殖,例如结肠癌等癌症的治疗。
查看更多